Key Pharmaceutical Intermediate for Elacestrant
Unlock advanced breast cancer therapies with our high-purity Elacestrant intermediate.
Get a Quote & SampleProduct Core Value
(R)-6-(2-(ethylamino)-4-methoxyphenyl)-5,6,7,8-tetrahydronaphthalen-2-ol
This high-quality pharmaceutical intermediate is essential for the synthesis of Elacestrant, a groundbreaking SERD used in the treatment of specific types of breast cancer. Its precise chemical structure and purity ensure the efficacy and safety of the final Active Pharmaceutical Ingredient (API), supporting critical advancements in oncology drug development.
- Facilitate Elacestrant intermediate synthesis with a reliable supply of this crucial compound.
- Buy (R)-6-(2-(ethylamino)-4-methoxyphenyl)-5,6,7,8-tetrahydronaphthalen-2-ol from a trusted pharmaceutical intermediate manufacturer committed to quality.
- Discover custom synthesis API solutions that meet the rigorous demands of pharmaceutical research and production.
- Secure your supply chain with an Elacestrant RAD-1901 supplier focused on purity and consistent product delivery.
Advantages Provided by the Product
Exceptional Purity
Achieve superior results in your API synthesis by utilizing this intermediate, manufactured to exacting standards for maximum purity.
Critical for SERD Development
Play a vital role in advancing therapies like Elacestrant, contributing to new treatment options for breast cancer patients.
Reliable Manufacturing
Partner with a dedicated pharmaceutical intermediate manufacturer that ensures consistent quality and dependable supply.
Key Applications
Pharmaceutical Synthesis
Essential building block in the complex chemical synthesis pathways for targeted cancer therapeutics like Elacestrant.
Drug Development
Supports the research and development of new Selective Estrogen Receptor Degraders (SERDs) and other oncology drugs.
Medical Research
Enables scientific exploration into the mechanisms and applications of novel pharmaceutical compounds.
Custom Synthesis Projects
A key component for custom synthesis projects requiring high-grade intermediates for specialized pharmaceutical applications.